ACAD R&D to Revenue
Acadia Pharmaceuticals Inc · R&D to Revenue
ACAD R&D to Revenue
Latest reported30.69%period ending
ACAD FY R&D/Revenue (225.60% → 30.69%)
Latest values, visible window
High-resolution chart · PNG
ACAD r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 30.686% | |
| 31.6611% | |
| 48.4032% | |
| 69.9054% | |
| 49.4511% | |
| 72.2414% | |
| 70.8941% | |
| 83.627% | |
| 119.4458% | |
| 572.8694% | |
| 121,096.7213% | |
| 50,501.6667% | |
| 2,333.7991% | |
| 383.0039% | |
| 837.3972% | |
| 48.8406% | |
| 649.8672% | |
| 3,569.1824% | |
| 766.9358% | |
| 607.3774% | |
| 281.5549% | |
| 509.3934% | |
| 229.5213% | |
| 237.7573% | |
| 352.4502% | |
| 225.603% |